PL2480205T3 - Iniekcyjna wodna kompozycja oftalmiczna i sposób jej stosowania - Google Patents

Iniekcyjna wodna kompozycja oftalmiczna i sposób jej stosowania

Info

Publication number
PL2480205T3
PL2480205T3 PL10757550.8T PL10757550T PL2480205T3 PL 2480205 T3 PL2480205 T3 PL 2480205T3 PL 10757550 T PL10757550 T PL 10757550T PL 2480205 T3 PL2480205 T3 PL 2480205T3
Authority
PL
Poland
Prior art keywords
ophthalmic composition
injectable aqueous
aqueous ophthalmic
use therefor
therefor
Prior art date
Application number
PL10757550.8T
Other languages
English (en)
Inventor
Masood A. Chowhan
Thomas C. Hohman
Ernesto J. Castillo
Wesley Wehsin Han
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2480205T3 publication Critical patent/PL2480205T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL10757550.8T 2009-09-23 2010-09-21 Iniekcyjna wodna kompozycja oftalmiczna i sposób jej stosowania PL2480205T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24491609P 2009-09-23 2009-09-23

Publications (1)

Publication Number Publication Date
PL2480205T3 true PL2480205T3 (pl) 2016-09-30

Family

ID=43034434

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10757550.8T PL2480205T3 (pl) 2009-09-23 2010-09-21 Iniekcyjna wodna kompozycja oftalmiczna i sposób jej stosowania

Country Status (15)

Country Link
US (3) US20110071091A1 (pl)
EP (1) EP2480205B1 (pl)
JP (2) JP5732058B2 (pl)
KR (2) KR20120069741A (pl)
CN (1) CN102695497B (pl)
AR (1) AR078293A1 (pl)
AU (1) AU2010298480B2 (pl)
BR (1) BR112012006642A2 (pl)
CA (1) CA2772795A1 (pl)
ES (1) ES2568462T3 (pl)
MX (1) MX2012003196A (pl)
PL (1) PL2480205T3 (pl)
TW (1) TWI492769B (pl)
WO (1) WO2011037908A1 (pl)
ZA (1) ZA201201438B (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2441873T3 (es) 2005-05-26 2014-02-06 Aldexa Therapeutics, Inc. Derivados de quinolina para el tratamiento de enfermedades retinianas
TWI492769B (zh) 2009-09-23 2015-07-21 Alcon Res Ltd 可注射的水性眼用組成物及其使用之方法
US9498035B2 (en) 2012-12-21 2016-11-22 Coopervision International Holding Company, Lp Silicone hydrogel contact lenses for sustained release of beneficial polymers
US20140178327A1 (en) 2012-12-21 2014-06-26 Coopervision International Holding Company, Lp Antimicrobial Ophthalmic Devices
EP2948149A4 (en) 2013-01-23 2016-12-14 Aldeyra Therapeutics Inc BY TOXIC ALDEHYDIC DISEASES AND TREATMENT
US20150164882A1 (en) 2013-07-22 2015-06-18 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
US20160279055A1 (en) * 2013-07-22 2016-09-29 Imprimis Pharmaceuticals, Inc. Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
US20170119885A1 (en) * 2014-04-28 2017-05-04 Hampton Technologies Ophthalmic compositions and methods for treating eyes
US20150366311A1 (en) 2014-06-19 2015-12-24 Coopervision International Holding Company, Lp Protection of Contact Lenses from Microbial Contamination Caused by Handling
WO2016197005A1 (en) * 2015-06-05 2016-12-08 Kato Pharmaceuticals, Inc. Extended release urea compositions
KR102664994B1 (ko) 2015-08-21 2024-05-13 알데이라 테라퓨틱스, 아이엔씨. 중수소화 화합물 및 이의 용도
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
WO2017035408A1 (en) 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
AU2017264697A1 (en) 2016-05-09 2018-11-22 Aldeyra Therapeutics, Inc. Combination treatment of ocular inflammatory disorders and diseases
WO2018005552A1 (en) 2016-06-27 2018-01-04 Achillion Pharmaceuticals, Inc. Quinazoline and indole compounds to treat medical disorders
KR102632860B1 (ko) 2017-03-01 2024-02-02 아칠리온 파르마세우티칼스 인코포레이티드 의학적 장애의 치료를 위한 아릴, 헤테로아릴, 및 헤테로사이클릭 약학적 화합물
US11040039B2 (en) 2017-10-10 2021-06-22 Aldeyra Therapeutics, Inc. Treatment of inflammatory disorders
WO2020033344A1 (en) 2018-08-06 2020-02-13 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
US20230022157A1 (en) 2018-08-20 2023-01-26 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
WO2020081723A1 (en) 2018-10-16 2020-04-23 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
WO2020118045A1 (en) * 2018-12-05 2020-06-11 Aldeyra Therapeutics, Inc. Injectable formulations
CN113784954A (zh) 2019-05-02 2021-12-10 奥尔德拉医疗公司 多晶型化合物和其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0244178A3 (en) * 1986-04-28 1989-02-08 Iolab, Inc Intraocular dosage compositions and method of use
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
MX2007002692A (es) 2004-09-24 2007-05-16 Hercules Inc Poligalactomanano cationico de alto grado de sustitucion para productos de cuidado de la piel.
US20060258698A1 (en) 2005-02-09 2006-11-16 Sreenivasu Mudumba Liquid formulations for treatment of diseases or conditions
CN100433805C (zh) * 2005-06-29 2008-11-12 上海广电（集团）有限公司中央研究院 一种数字电视接收机及其信号传递方法
US8168584B2 (en) * 2005-10-08 2012-05-01 Potentia Pharmaceuticals, Inc. Methods of treating age-related macular degeneration by compstatin and analogs thereof
MX351152B (es) * 2005-10-08 2017-10-04 Potentia Pharmaceuticals Inc Compstatina y analogos de la misma para tratar trastornos oculares.
US8492400B2 (en) 2006-02-09 2013-07-23 Santen Pharmaceutical Co., Ltd. Stable formulations, and methods of their preparation and use
EP2207530A4 (en) * 2007-10-02 2013-09-11 Potentia Pharmaceuticals Inc DELAYED RELEASE OF COMPSTATIN ANALOG FROM GELEN
US8530189B2 (en) 2008-10-16 2013-09-10 Kathleen Cogan Farinas Sustained drug delivery system
EP2349339A4 (en) * 2008-10-16 2015-01-07 Kathleen Cogan Farinas EXTENDED MEDICATION DELIVERY SYSTEM
TWI492769B (zh) 2009-09-23 2015-07-21 Alcon Res Ltd 可注射的水性眼用組成物及其使用之方法
NZ603345A (en) * 2010-05-05 2014-12-24 Alcon Res Ltd Stabilized ophthalmic galactomannan formulations

Also Published As

Publication number Publication date
CA2772795A1 (en) 2011-03-31
JP5732058B2 (ja) 2015-06-10
JP2015129194A (ja) 2015-07-16
TW201111003A (en) 2011-04-01
ZA201201438B (en) 2013-05-29
AR078293A1 (es) 2011-10-26
KR20170008895A (ko) 2017-01-24
BR112012006642A2 (pt) 2016-05-03
KR20120069741A (ko) 2012-06-28
US20140094419A1 (en) 2014-04-03
MX2012003196A (es) 2012-04-30
TWI492769B (zh) 2015-07-21
CN102695497A (zh) 2012-09-26
US9446093B2 (en) 2016-09-20
EP2480205A1 (en) 2012-08-01
US20160361254A1 (en) 2016-12-15
CN102695497B (zh) 2016-01-06
AU2010298480A1 (en) 2012-03-29
WO2011037908A1 (en) 2011-03-31
EP2480205B1 (en) 2016-03-16
ES2568462T3 (es) 2016-04-29
JP2013505934A (ja) 2013-02-21
US20110071091A1 (en) 2011-03-24
AU2010298480B2 (en) 2014-08-07

Similar Documents

Publication Publication Date Title
ZA201201438B (en) Injectable aqueous ophthalmic composition and method of use therefor
HK1194071A1 (en) Certain triazolopyrazines, compositions thereof and methods of use therefor
EP2398998A4 (en) POSITION STOP MECHANISM AND METHOD
IL215251A0 (en) Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
ZA201107789B (en) Antimicrobial composition and related method of use
IL236830A0 (en) Diazahomoredene derivatives and methods of using them
EP2411024A4 (en) Variants of factor viii and associated methods of use
EP2262450A4 (en) IMPLANTS AND METHODS OF USE
HK1164832A1 (en) Piceatannol-containing composition and method of producing piceatannol- containing composition
EP2493550A4 (en) ELECTRO-OPTICAL FABRIC STIMULATOR AND METHOD OF USE THEREOF
EP2482814A4 (en) METHOD AND COMPOSITIONS FOR TREATING OKULAR FIBROSIS
EP2464227A4 (en) COMPOUNDS AND METHODS OF USE
GB2479020B (en) Toothbrush and method of use
EP2393787A4 (en) CADHERINE 11 INHIBITORS AND METHOD FOR THEIR USE
ZA201202892B (en) Ophthalmic formulation and method of manufacture thereof
EP2300495A4 (en) SOLUTIONS FOR TISSUE MANIPULATION AND APPLICATION METHODS
EP2421923A4 (en) INK COMPOSITIONS AND USE
EP2328441A4 (en) CONTAINER AND METHOD FOR ITS USE
GB201210536D0 (en) Composition, use and method of preparation thereof
HK1166953A1 (en) Compositions and methods of use
EP2470016A4 (en) SYNERGISTIC COMPOSITION AND METHOD OF USE
EP2427052A4 (en) METHODS AND COMPOSITIONS FOR USE IN THE TREATMENT OF OPHTHALMIC DISORDERS
HK1174620A1 (zh) 吲唑基取代的二氫異噁唑並吡啶及其使用方法
IL196455A0 (en) Corkscrew and method of use
GB0920931D0 (en) Bracket assembly and method of use thereof